tiprankstipranks
Orthofix Medical (OFIX)
NASDAQ:OFIX
US Market
Want to see OFIX full AI Analyst Report?

Orthofix Medical (OFIX) Blogger Opinions & Sentiment

93 Followers

Blogger Sentiment

Bullish: 66.67%
Sector Average
Bullish
OFIX Blogger sentiment is based on 3 Blogger Opinions. The Blogger sentiment is more Bullish than other stocks in the Healthcare sector.

Blogger Article Distribution

ArticleDistribution
33% SeekingAlpha
33% Zacks
34% GuruFocus
The distribution of articles among the main online Financial Blogging platforms.

Top Blogger Bearish Predictions

Not enough top blogger opinions at this time
Please return soon. This page is being updated.
Recent negative articles by top bloggers.

Top Blogger Bullish Predictions

Orthofix (OFIX) -- Navigating Challenges with Long-Term Value | Reweyassetmanagement Q2 2026
GuruFocus
Orthofix (OFIX) Q2 Earnings and Revenues Surpass Estimates
Zacks
Recent positive articles by top bloggers.

Financial Blogger Predictions​​

Blogger Performance
Any
Any
Blogger Sentiment
Any
Any

FAQ

What do Seeking Alpha bloggers think of OFIX?
Seeking Alpha’s Zach Bristow has a Neutral Sentiment.
    What do Motley Fool contributors think of OFIX?
    Currently there's no blogger sentiment for OFIX.
    What Is OFIX’s Blogger Sentiment?
    OFIX’s Blogger Sentiment is Bullish.
      What was the most recent blogger prediction for OFIX?
      The most recent blogger prediction for OFIX was made by GuruFocus News, who was Bullish on the stock.
        How can I follow the stock ratings of top Top Financial Bloggers?
        Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Stocks with the Highest Top Blogger Ratings in the Healthcare sector
          CADLCandel Therapeutics
          MLTXMoonLake Immunotherapeutics
          DFTXDefinium Therapeutics
          SENSSenseonics Holdings
          TGTXTG Therapeutics